Comprehensive genomic profiling—choosing the best testing strategy and assay option

Comprehensive genomic profiling (CGP) is advancing precision oncology research through the analysis of multiple relevant biomarkers in a single next-generation sequencing (NGS) test. Some on-market hybrid-capture NGS assays prevent >57% of clinical research samples from being eligible for testing due to high sample input requirements and other technical limitations. Our speakers will discuss how the Ion Torrent Oncomine Comprehensive Assay Plus system eliminates these limitations and enables new capabilities like assessment of HRD associated genomic instability.

Speakers:

Dr. Philip Martin Jermann, PhD
Dr. Philip Martin Jermann, PhD
Dr. Andreas Jung, PhD
Dr. Andreas Jung, PhD

(*Indicates a mandatory field)